¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fructose intolerance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® intolerance ÇÑ±Û ¸ø°ßµõ(Áõ)
¼³¸í   
  »ó¿ë·®ÀÇ ¾à¹°À» »ç¿ëÇßÀ½¿¡µµ ºÒ±¸Ç졒ʡú·®ÀÇ °æ¿ì¿Í ¶È°°Àº ÁÖÀÛ¿ëÀÇ °úÀ×¹ßÇöÀ» Çϴ °æ¿ì ºÒ³»¼ºÀ̶ó°í ÇÑ´Ù. »ýü Ãø¿¡ ¾î¶°ÇÑ ÀáÀçÀû ÀåÇØ°¡ Á¸ÀçÇϰųª, ´Ù¸¥ ¾àǰÀ̳ª ±× Ã·°¡¹° µî°úÀÇ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ, ±× ¾à¹°ÀÇ Èí¼ö, ´ë»ç, ¹è¼³ µî¿¡ º¯È­°¡ ÀϾ, °á°úÀûÀ¸·Î ±× ¾à¹°ÀÇ Ç÷Áß³óµµÀÇ »ó½ÂÀ» ÃÊ·¡Çϱ⠶§¹®À̶ó°í »ý°¢µÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fructose
    °ú´ç, ÇÁ·èÅä¿À½º
  • alcoholic intolerance
    ¾ËÄڿøø°ßµõ(Áõ)
  • cold intolerance
    ÃßÀ§¸ø°ßµõ(Áõ)
  • carbohydrate intolerance
    ź¼öÈ­¹°¸ø°ßµõ(Áõ), ź¼öÈ­¹°ºÒ³»¼º
  • fatty food intolerance
    Áö¹æ½Ä¸ø°ßµõ(Áõ)
  • glucose intolerance
    Æ÷µµ´ç¸ø°ßµõ(Áõ), Æ÷µµ´çºÒ³»¼º
  • intolerance
    ¸ø°ßµõ(Áõ), ºÒ³»¼º
  • lactose intolerance
    Á¥´ç¸ø°ßµõÁõ, Á¥´çºÒ³»¼º
  • milk intolerance
    ¿ìÀ¯¸ø°ßµõ(Áõ)
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fructose
    °ú´ç, ÇÁ·èÅä¿À½º
  • intolerance
    ¸ø°ßµõ(Áõ)
  • cold intolerance
    ÇÑ·©¸ø°ßµõ(Áõ)
  • glucose intolerance
    Æ÷µµ´ç¸ø°ßµõ(Áõ), ´çºÒ³»¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fructose
    °ú´ç, ÇÁ·èÅä¿À½º
  • alcoholic intolerance
    ¾ËÄڿøø°ßµõ(Áõ)
  • carbohydrate intolerance
    ´çÁú¸ø°ßµõ(Áõ)
  • cold intolerance
    ÇÑ·©¸ø°ßµõ¼º
  • fatty food intolerance
    Áö¹æ½Ä¸ø°ßµõ(Áõ)
  • intolerance
    ¸ø°ßµõ(Áõ)
  • milk intolerance
    ¿ìÀ¯¸ø°ßµõ(Áõ)
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fructose intolerance
    ÇÁ¶ôÅ佺ºÒ³»¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hereditary fructose intolerance
    À¯Àü¼º ÇÁ·èÅä¿À½º ºÒ³»Áõ(¡­ÝÕÒ±ñø).
  • glucose intolerance
    Æ÷µµ´ç ºÒ³»¼º
  • Fructose
    °ú´ç(ÍýÓØ)
  • Fructose-2, 6-biphosphate
    °ú´ç(ÍýÓØ)-2,6-ÀÌÀλê(ì£ìÝß«)
  • Henry fructose test
    Ç°ú´ç°Ë»ç
  • fructose
    °ú´ç
  • fructose aldolase
    ÇÁ¶ôÅ佺¾Ëµµ¶óÁ¦
  • fructose tolerance test
    ÇÁ¶ôÅ佺ºÎÇϽÃÇè.
  • fructose tolerance test
    ÇÁ¶ôÅ佺ºÎÇϽÃÇè
  • fructose-1-phosphate aldolase
    ÇÁ¶ôÅ佺-1-Æ÷½ºÆäÀÌÆ®¾Ëµ¹¶óÁ¦
  • fructose-related disorder
    ÇÁ¶ôÅ佺°ü·ÃÀå¾Ö<--Áúº´>
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fructose intolerance
    ÇÁ¶ôÅ佺ºÒ³»¼º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • familial fructose and galactose intolerance
    °¡Á·¼º ÇÁ·°Åä¿À½º ¹× °¥¶ôÅä ¿À½º ºÒ³»Àμº(¡­ÝÕÒ±ìÑàõ).
  • hereditary fructose intolerance
    À¯Àü¼º ÇÁ·èÅä¿À½º ºÒ³»Áõ(¡­ÝÕÒ±ñø).
  • familial fructose and galactose intol
    °¡Á·¼º ÇÁ·°Åä¿À½º ¹× °¥¶ôÅä ¿À½º
  • fructose
    °ú´ç
  • fructose
    ÇÁ¶ôÅ佺
  • fructose
    ÇÁ¶ôÅ佺, °ú´ç.
  • fructose aldolase
    ÇÁ¶ôÅ佺¾Ëµµ¶óÁ¦
  • fructose tolerance test
    ÇÁ¶ôÅ佺ºÎÇϽÃÇè
  • fructose tolerance test
    ÇÁ¶ôÅ佺ºÎÇϽÃÇè.
  • fructose-1-phosphate aldolase
    ÇÁ¶ôÅ佺-1-Æ÷½ºÆäÀÌÆ®¾Ëµ¹¶óÁ¦
  • fructose-related disorder
    ÇÁ¶ôÅ佺°ü·ÃÀå¾Ö<--Áúº´>
  • alcoholic intolerance
    ¾ËÄڿúҳ»¼º(¡­ÝÕÒ±àõ).
  • carbohydrate intolerance
    ´çÁúºÒ³»¼º(ÓØòõÝÕÒ±àõ)
  • cold intolerance
    ÇÑ·©ºÒ³»¼º
  • fatty food intolerance
    Áö¹æ½ÄºÒ³»¼º(¡­ãÝÝÕÒ±àõ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fructose intolerance
    ÇÁ¶ôÅ佺 °ÅºÎÁõ(ËÞÜúñø)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • active fructose
    Ȱ¼º(üÀàõ)ÇÁ¶ôÅäÁî
  • fructose
    ÇÁ¶ôÅ佺
  • "fructose-1,6-bisphosphate"
    "ÇÁ¶ôÅ佺-1,6-¾çÀλê(å»×òß«)"
  • fructose-6-phosphate
    ÇÁ¶ôÅ佺-6-Àλê(×òß«)
  • lactose intolerance
    ¶ôÅ佺°ÅºÎÁõ(ËÞÜúñø)
  • lysine intolerance
    ¶óÀ̽ŰźÎÁõ(ËÞÜúñø)
  • milk intolerance
    Á£ °ÅºÎÁõ(ËÞÜúñø)
  • sucrose intolerance
    ½´Å©·Î½º °ÅºÎÁõ(ËÞÜúñø)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HFI hereditary fructose intolerance; human fibroblast interferon
AMI acquired monosaccharide intolerance; acute myocardial infarction; amitriptyline; anterior myocardial...
ASA acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes...
FCI fixed-cell immunofluorescence; food chemical intolerance
FI fasciculus intrafascicularis; fever caused by infection; fibrinogen; fixed interval; flame ionizatio...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HFI Hereditary Fructose Intolerance
CMPI Cow's Milk Protein Intolerance
LPI Lysinuric protein intolerance
OI Orthostatic Intolerance
PFK-2/FBPase-2 6-Phosphofructo-2-kinase/fructose 2,6-bisphosphatase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fructose test
    °ú´ç ½ÃÇè
  • Henry fructose test
    Ç °ú´ç °Ë»ç
  • carbohydrate intolerance
    ´çÁú ºÒ³»¼º
  • cold intolerance
    ÇÑ·© ºÒ³»¼º
  • heat intolerance
    ³»¿­¼º
    ¿­¿¡ °ßµð´Â ¼ºÁú.
  • orthostatic intolerance
    ±â¸³¼º Á¶Àý Àå¾Ö
    ´¯°Å³ª Àå½Ã°£ ¾É¾Æ ÀÖ´Ù°¡ °©ÀÚ±â ÀϾ ¶§ ³ú, ½ÉÀå µîÀÇ Ç÷·ù°¡ °¨¼ÒÇÏ¿© Çö±âÁõ, ±¸Åä, ½É°è Ç×Áø, ÀÇ½Ä »ó½Ç µîÀÌ ÀϾ´Â Áõ¼¼. ±â¸³¼º Çö±âÁõÀ̶ó°íµµ ÇÑ´Ù. Á¤»óÀÎÀÎ °æ¿ì¿¡´Â ±â¸³ ½Ã¿¡ ¸»ÃÊÇ÷°üÀÌ ¼öÃàÇϸ鼭 Ç÷¾Ð, ¼øÈ¯ Ç÷·®À» À¯Áö½ÃŰ·Á´Â ±âÀüÀÌ ÀÖÀ¸³ª, ÀúÇ÷¾ÐÁõ, ÀÚÀ²½Å°æ ½ÇÁ¶ ¹× ³úÇϼöü, »ý½Ä¼± µîÀÇ ±â´É¿¡ ÀÌ»óÀÌ ÀÖÀ» °æ¿ì, ±âÀü¿¡ Àå¾Ö°¡ ¹ß»ýÇÏ¿© ÀÌ Áõ¼¼¸¦ °¡Á®¿Â´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
fructose intolerance An autosomal recessive fructose metabolism disorder due to deficient fructose-1-phosphate aldolase (ec 2.1.2.13) activity, resulting in accumulation of fructose-1-phosphate. The accumulated fructose-1-phosphate inhibits glycogenolysis and gluconeogenesis, causing severe hypoglycaemia following ingestion of fructose. Prolonged fructose ingestion in infants leads ultimately to hepatic failure and death. Patients develop a strong distaste for sweet food, and avoid a chronic course of the disease by remaining on a fructose- and sucrose-free diet.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
hereditary fructose intolerance A metabolic error due to deficiency of hepatic fructose 1,6-bisphosphate aldolase B (which also acts on fructose 1-phosphate); the second enzyme in the specific fructose pathway; vomiting and hypoglycaemia follow ingestion of fructose; prolonged fructose ingestion in young children results in failure to thrive and in jaundice, hepatomegaly, albuminuria, aminoaciduria, and sometimes cachexia and death; autosomal recessive inheritance in most families.
(05 Mar 2000)
fructose-6-phosphate,2-kinase-fructose-2,6-bisphosphatase <chemical> From rat skeletal muscle and liver; catalyses the synthesis and degradation of fructose 2,6-bisphosphate; contains EC 2.7.1.105 and EC 3.1.3.46
Synonym: fru-kinase-fru-bisphosphatase, f kinase-f-bisphosphatase, 6-phosphofructo 2-kinase-fructose 2,6-bisphosphatase, 6-pf-2-k-fru-2,6-p(2)ase
(26 Jun 1999)
glucose intolerance A pathological state in which the fasting plasma glucose level is less than 140 mg per deciliter and the 30-, 60-, or 90-minute plasma glucose concentration following a glucose tolerance test exceeds 200 mg per deciliter. This condition is seen frequently in diabetes mellitus but also occurs with other diseases.
(12 Dec 1998)
intolerance Inability to withstand, sensitivity, as to a drug.
Origin: L. Tolerare = to bear
(18 Nov 1997)
lactose intolerance A disorder characterised by abdominal cramps and diarrhoea after the consumption of food containing lactose (for example milk, ice cream), believed to occur due to a deficiency of intestinal lactase (enzyme that breaks down lactose), may appear first in young adults who have previously tolerated milk well as infants.
(27 Sep 1997)
lysinuric protein intolerance An autosomal recessive disorder characterised by elevated levels of dibasic amino acids (e.g., l-lysine, l-arginine, and l-ornithine) in the urine; apparently due to a defect in dibasic amino acid transport.
(05 Mar 2000)
glucose-1-fructose-2-oxidoreductase <enzyme> Catalyses intermolecular oxidation-reduction of glucose and fructose to form gluconolactone and sorbitol; contains tightly bound nadp as h+ carrier; does not require added cofactor
Registry number: EC 1.1.1.-
(26 Jun 1999)
glucose-fructose oxidoreductase <enzyme> Isolated from zymomonas mobilis; catalyses the formation of sorbitol and glucono-delta-lactone from glucose and fructose; enzyme contains tightly bound nadp+
Registry number: EC 1.1.99.-
(26 Jun 1999)
glutamine-fructose-6-phosphate transaminase (isomerizing) <enzyme> An enzyme that catalyses the synthesis of fructose-6-phosphate plus glutamine from glutamate plus glucosamine-6-phosphate.
Chemical name: L-Glutamine:D-fructose-6-phosphate aminotransferase (hexose-isomerizing)
Registry number: EC 2.6.1.16
(12 Dec 1998)
D-fructose 5-dehydrogenase <enzyme> Catalyses the oxidation of fructose with any acceptor to 5-ketofructose and reduced acceptor
Registry number: EC 1.1.99.11
(26 Jun 1999)
ferric fructose A potassium-iron-fructose; a haematinic drug.
(05 Mar 2000)
6-phosphofructo-2-kinase-fructose-2,6-bisphosphatase <chemical> Hepatic bifunctional enzyme that both degrades and synthesises fructose-2,6-bisphosphate
Synonym: 6pf-2-k-fru-2,6-p(2)ase, hepatic 6-phosphofructo-2-kinase, hepatic fructose-2,6-bisphosphatase, pfk-2 (liver), pbpase-2 (liver)
(26 Jun 1999)
fructose <biochemistry> A 6 carbon sugar (hexose) abundant in plants. Fructose has its reducing group (carbonyl) at C2 and thus is a ketose, in contrast to glucose that has its carbonyl at C1 and thus an aldose. Sucrose, common table sugar, is the nonreducing disaccharide formed by an alpha linkage from C1 of glucose to C2 of fructose (latter in furanose form). Fructose is a component of polysaccharides such as inulin, levan.
(18 Nov 1997)
fructose 1,6-bisphosphate <biochemistry> This key intermediate in glycolysis and gluconeogenesis (a hexose diphosphate) was discovered by Arthur Harden and William Young in 1905.
In the third step of glycolysis, fructose 6-phosphate and ATP are converted to fructose 1,6-bisphosphate and ADP with the aid of phosphofructokinase. In step 4, fructose 1,6 bisphosphate (with the aid of aldolase) is cleaved into duhydroxyacetone phosphate and glyceraldehyde 3-phosphate.
Synonym: hexosebisphosphatase, hexosediphosphatase.
(08 Mar 2000)
fructose-1,6-diphosphatase deficiency An autosomal recessive fructose metabolism disorder due to absent or deficient fructose-1,6-diphosphatase activity. Gluconeogenesis is impaired, resulting in accumulation of gluconeogenic precursors (e.g., amino acids, lactate, ketones) and manifested as hypoglycaemia, ketosis, and lactic acidosis. Episodes in the newborn infant are often lethal. Later episodes are often brought on by fasting and febrile infections. As patients age through early childhood, tolerance to fasting improves and development becomes normal.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Fructose Intolerance - »õâ An autosomal recessive fructose metabolism disorder due to deficient fructose-1-phosphate aldolase (EC 2.1.2.13) activity, resulting in accumulation of fructose-1-phosphate. The accumulated fructose-1-phosphate inhibits glycogenolysis and gluconeogenesis, causing severe hypoglycemia following ingestion of fructose. Prolonged fructose ingestion in infants leads ultimately to hepatic failure and death. Patients develop a strong distaste for sweet food, and avoid a chronic course of the disease by remaining on a fructose- and sucrose-free diet.
    Synonyms : Fructose Intolerances, Intolerance, Fructose, Intolerances, Fructose
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 1 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fructose
    °ú´ç
  • intolerance
    µµ·®ÀÌ Á¼Àº
  • intolerance
    ÂüÀ»¼ö ¾øÀ½;¾Æ·®ÀÌ ¾øÀ½;¿ËÁ¹;ÆíÇù(narrowmindedness)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á